ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°.
Π¦ΠΈΡΡΠΎΠ· ΠΏΠ΅ΡΠ΅Π½ΠΈ.
ΠΠ±Π·ΠΎΡ ΠΈΠ½ΠΎΡΡΡΠ°Π½Π½ΠΎΠΉ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
Lucey MR, Brown KA, Everson GT, et al: Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3:628β637, 1997. Lucey MR, Brown KA, Everson GT, et al: Minimal criteria for placement of adults on the… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°. Π¦ΠΈΡΡΠΎΠ· ΠΏΠ΅ΡΠ΅Π½ΠΈ. ΠΠ±Π·ΠΎΡ ΠΈΠ½ΠΎΡΡΡΠ°Π½Π½ΠΎΠΉ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
1. Rosen HR, Shackleton CR, Martin P: Indications for and timing of liver transplantation. Med Clin North Am 80:1069−1102, 1996.
2. Carithers RL Jr: Liver transplantation. Liver Transpl Surg 6:122−135, 1999 Π@.
3. Rolachon A, Cordier L, Bacq Y, et al: Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial. Hepatology 22:1171−1174, 1995.
4. Rosen HR, Shackleton CR, Martin P: Indications for and timing of liver transplantation. Med Clin North Am 80:1069−1102, 1996.
5. Van Thiel DH: Liver transplantation: A history of the past and present with a vision of the future. In Maddrey WC, Sorrell MF (eds): Transplantation of the liver, ed 2. Norwalk, CT, Appleton & Lange, 1995, pp 1−12,.
6. Lucey MR, Brown KA, Everson GT, et al: Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3:628−637, 1997.
7. Carithers RL Jr: Liver transplantation. Liver Transpl Surg 6:122−135, 1999.
8. Lucey MR, Brown KA, Everson GT, et al: Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3:628−637, 1997.
9. Fattovich G, Giustina G, Degos F, et al: Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 113:463−472, 1997.
10. Centers for Disease Control and Prevention: General recommendations on immunization. Guidelines from the Immunization Practices Advisory Committee. Ann Intern Med 111:133−142, 1989 .
11. Duchini A, Viernes ME, Nyberg LM, et al: Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch Intern Med 160:113−115, 2000.
12., Keeffe EB: Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 90:201−205, 1995.
13. Vento S, Garofano T, Renzini C, et al: Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 338:286−290, 1998.
14. Keeffe EB, Iwarson S, McMahon BJ, et al: Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 27:881−886, 1998.
15. Ko WC, Chuang YC, Huang GC, et al: Infections due to non-O1 Vibrio cholerae in southern Taiwan: Predominance in cirrhotic patients. Clin Infect Dis 27:774−780, 1998.
16. Liaw YF, Tai DI, Chen TJ, et al: Alpha-fetoprotein changes in the course of chronic hepatitis: Relation to bridging hepatic necrosis and hepatocellular carcinoma. Liver 6:133−137, 1986.
17. Poulos JE, Cancio M, Conrad P, et al: Non 0−1 Vibrio cholerae septicemia and culture negative neutrocytic ascites in a patient with chronic liver disease. J Fla Med Assoc 81:676−678, 1994.
18. Runyon BA: Paracentesis of ascitic fluid: A safe procedure. Arch Intern Med 146:2259−2261, 1986.